STTK

MKT CAP:$403M

Shattuck Labs Inc

Market Cap

$403M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.58+$0.87 (+23.45%)

Jun 5, 2026

52W High $7.8852W Low $0.73

Company Details

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 block...

CEO

—

IPO Date

Oct 9, 2020

Website

www.shattucklabs.com

Key Metrics TTM

Revenue

$1M

-98.1% YoY

Net Income

-$50M

EPS (Diluted)

Free Cash Flow

-$41M

Revenue / Share

$0.01

Gross Margin

-172.6%

Operating Margin

-5266.4%

Net Margin

-4987.4%

FCF Margin

-4128.2%

P/S

402.7x

P/E

Earnings Reports

Q2 2026

Aug 14, 2026

PENDING

Q1 2026

May 7, 2026

$0-100.0%

FY 2025

Mar 5, 2026

$1M-82.5%

Q4 2025

Mar 5, 2026

$0-100.0%

Q3 2025

Nov 6, 2025

$1M-66.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee